SLC2A2 and Hyperglycemia: In the FBS patients due to nonfunctional GLUT2 mutation, defective uptake of monosaccharides and reduced glucose-stimulated secretion of insulin from pancreatic β-cells in the fed state causes hyperglycemia and hypergalactosemia [6].